Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2017

Open Access 01-10-2017 | Original Article

Cytokine gene polymorphism associations with congenital cytomegalovirus infection and sensorineural hearing loss

Authors: B. Kasztelewicz, J. Czech-Kowalska, B. Lipka, B. Milewska-Bobula, M. K. Borszewska-Kornacka, J. Romańska, K. Dzierżanowska-Fangrat

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2017

Login to get access

Abstract

Cytomegalovirus (CMV) is the most common viral agent of congenital infections and a leading nongenetic cause of sensorineural hearing loss (SNHL). The host immunologic factors that render a developing foetus prone to intrauterine CMV infection and development of hearing loss are unknown. The aim of this study was to assess the potential associations between the polymorphisms within cytokine and cytokine receptors genes, and the risk of congenital CMV infection, and the hearing outcome. A panel of 11 candidate single nucleotide polymorphisms (SNPs): TNF rs1799964, TNF rs1800629, TNFRSF1A rs4149570, IL1B rs16944, IL1B rs1143634, IL10 rs1800896, IL10RA rs4252279, IL12B rs3212227, CCL2 rs1024611, CCL2 rs13900, CCR5 rs333 was genotyped in 470 infants (72 with confirmed intrauterine CMV infection and 398 uninfected controls), and related to congenital CMV infection, and the outcome. In multivariate analysis, the IL1B rs16944 TT and TNF rs1799964 TC genotypes were significantly associated with intrauterine CMV infection (aOR = 2.32; 95% CI, 1.11–4.89; p = 0.032, and aOR = 2.17, 95% CI, 1.25–3.77; p = 0.007, respectively). Twenty-two out of 72 congenitally infected newborns had confirmed SNHL. Carriers of CT or TT genotype of CCL2 rs13900 had increased risk of hearing loss at birth and at 6 months of age (aOR = 3.59; p = 0.028 and aOR = 4.10; p = 0.039, respectively). This is the first study to report an association between SNPs in IL1B, TNF, and CCL2, and susceptibility to congenital CMV infection (IL1B and TNF) and SNHL (CCL2).
Appendix
Available only for authorised users
Literature
1.
go back to reference Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253–276CrossRefPubMed Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17(4):253–276CrossRefPubMed
2.
go back to reference Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344(18):1366–1371CrossRefPubMed Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344(18):1366–1371CrossRefPubMed
3.
go back to reference Soper DE (2013) Congenital cytomegalovirus infection: an obstetrician’s point of view. Clin Infect Dis 57(Suppl 4):S171–S173CrossRefPubMed Soper DE (2013) Congenital cytomegalovirus infection: an obstetrician’s point of view. Clin Infect Dis 57(Suppl 4):S171–S173CrossRefPubMed
5.
go back to reference Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363CrossRefPubMed Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363CrossRefPubMed
7.
go back to reference Mocarski ES (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10(7):332–339CrossRefPubMed Mocarski ES (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10(7):332–339CrossRefPubMed
8.
go back to reference Noriega V, Redmann V, Gardner T, Tortorella D (2012) Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54(1–3):140–151CrossRefPubMed Noriega V, Redmann V, Gardner T, Tortorella D (2012) Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 54(1–3):140–151CrossRefPubMed
9.
go back to reference Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D (2014) Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro. J Virol 88(16):9391–9405CrossRefPubMedPubMedCentral Noriega VM, Haye KK, Kraus TA, Kowalsky SR, Ge Y, Moran TM, Tortorella D (2014) Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro. J Virol 88(16):9391–9405CrossRefPubMedPubMedCentral
10.
go back to reference Hamilton ST, Scott G, Naing Z, Iwasenko J, Hall B, Graf N, Arbuckle S, Craig ME, Rawlinson WD (2012) Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One 7(12):e52899CrossRefPubMedPubMedCentral Hamilton ST, Scott G, Naing Z, Iwasenko J, Hall B, Graf N, Arbuckle S, Craig ME, Rawlinson WD (2012) Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One 7(12):e52899CrossRefPubMedPubMedCentral
11.
go back to reference Scott GM, Chow SS, Craig ME, Pang CN, Hall B, Wilkins MR, Jones CA, Lloyd AR, Rawlinson WD (2012) Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205(8):1305–1310CrossRefPubMed Scott GM, Chow SS, Craig ME, Pang CN, Hall B, Wilkins MR, Jones CA, Lloyd AR, Rawlinson WD (2012) Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205(8):1305–1310CrossRefPubMed
12.
go back to reference Loeffler J, Steffens M, Arlt EM, Toliat MR, Mezger M, Suk A, Wienker TF, Hebart H, Nürnberg P, Boeckh M, Ljungman P, Trenschel R, Einsele H (2006) Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 44(5):1847–1850CrossRefPubMedPubMedCentral Loeffler J, Steffens M, Arlt EM, Toliat MR, Mezger M, Suk A, Wienker TF, Hebart H, Nürnberg P, Boeckh M, Ljungman P, Trenschel R, Einsele H (2006) Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 44(5):1847–1850CrossRefPubMedPubMedCentral
13.
go back to reference Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al Najjar A, Boulanger MD, Houssaini TS, Marliere JF, Lebranchu Y, Baron C (2008) Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplantation 85(10):1406–1411CrossRefPubMed Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al Najjar A, Boulanger MD, Houssaini TS, Marliere JF, Lebranchu Y, Baron C (2008) Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplantation 85(10):1406–1411CrossRefPubMed
14.
go back to reference Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A, Lewis RA, Smith MW, Troyer JL, O’Brien SJ, Group SR (2010) Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis 202(4):606–613CrossRefPubMedPubMedCentral Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A, Lewis RA, Smith MW, Troyer JL, O’Brien SJ, Group SR (2010) Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis 202(4):606–613CrossRefPubMedPubMedCentral
15.
go back to reference Hurme M, Helminen M (1998) Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes. Scand J Infect Dis 30(5):447–449CrossRefPubMed Hurme M, Helminen M (1998) Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes. Scand J Infect Dis 30(5):447–449CrossRefPubMed
16.
go back to reference McAulay KA, Haque T, Crawford DH (2009) Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer 101(6):1019–1027CrossRefPubMedPubMedCentral McAulay KA, Haque T, Crawford DH (2009) Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer 101(6):1019–1027CrossRefPubMedPubMedCentral
17.
go back to reference Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivnanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk H-D, Reinke P (2007) Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 84(3):387–391CrossRefPubMed Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivnanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk H-D, Reinke P (2007) Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 84(3):387–391CrossRefPubMed
18.
go back to reference Bogunia-Kubik K, Jaskula E, Lange A (2007) The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 40(2):145–150CrossRefPubMed Bogunia-Kubik K, Jaskula E, Lange A (2007) The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 40(2):145–150CrossRefPubMed
19.
go back to reference zur Hausen A, Crusius JB, Murillo LS, Alizadeh BZ, Morré SA, Meijer CJ, van den Brule AJ, Peña AS (2003) IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma. Int J Cancer 107(5):866–867CrossRefPubMed zur Hausen A, Crusius JB, Murillo LS, Alizadeh BZ, Morré SA, Meijer CJ, van den Brule AJ, Peña AS (2003) IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma. Int J Cancer 107(5):866–867CrossRefPubMed
20.
go back to reference Hurme M, Helminen M (1998) Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol 48(3):219–222CrossRefPubMed Hurme M, Helminen M (1998) Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand J Immunol 48(3):219–222CrossRefPubMed
21.
go back to reference Helminen ME, Kilpinen S, Virta M, Hurme M (2001) Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 184(6):777–780CrossRefPubMed Helminen ME, Kilpinen S, Virta M, Hurme M (2001) Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 184(6):777–780CrossRefPubMed
22.
go back to reference Hurme M, Santtila S (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28(8):2598–2602CrossRefPubMed Hurme M, Santtila S (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28(8):2598–2602CrossRefPubMed
23.
go back to reference Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Peña AS (1995) Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102(2):379–383CrossRefPubMedPubMedCentral Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Peña AS (1995) Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 102(2):379–383CrossRefPubMedPubMedCentral
24.
go back to reference Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, Császár A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158(1):233–239CrossRefPubMed Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, Császár A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158(1):233–239CrossRefPubMed
25.
go back to reference Abdi R, Tran TB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH (2002) Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13(3):754–758PubMed Abdi R, Tran TB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH (2002) Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13(3):754–758PubMed
26.
go back to reference Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22(15):1928–1929CrossRefPubMed Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22(15):1928–1929CrossRefPubMed
27.
go back to reference Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D’Alfonso S (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1(1):3–19CrossRefPubMed Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D’Alfonso S (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1(1):3–19CrossRefPubMed
28.
go back to reference El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412(6842):99CrossRefPubMed El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412(6842):99CrossRefPubMed
29.
go back to reference Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15(4):519–529CrossRefPubMed Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15(4):519–529CrossRefPubMed
30.
go back to reference Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50(6):1976–1983CrossRefPubMed Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50(6):1976–1983CrossRefPubMed
31.
go back to reference Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51(6):605–612CrossRefPubMed Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51(6):605–612CrossRefPubMed
32.
go back to reference Pham MH, Bonello GB, Castiblanco J, Le T, Sigala J, He W, Mummidi S (2012) The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance. PLoS One 7(11):e49498CrossRefPubMedPubMedCentral Pham MH, Bonello GB, Castiblanco J, Le T, Sigala J, He W, Mummidi S (2012) The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance. PLoS One 7(11):e49498CrossRefPubMedPubMedCentral
33.
go back to reference Letendre S, Marquie-Beck J, Singh KK, de Almeida S, Zimmerman J, Spector SA, Grant I, Ellis R, Group H (2004) The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J Neuroimmunol 157(1–2):193–196CrossRefPubMed Letendre S, Marquie-Beck J, Singh KK, de Almeida S, Zimmerman J, Spector SA, Grant I, Ellis R, Group H (2004) The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J Neuroimmunol 157(1–2):193–196CrossRefPubMed
34.
go back to reference Bradford RD, Yoo YG, Golemac M, Pugel EP, Jonjic S, Britt WJ (2015) Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons. PLoS Pathog 11(4):e1004774CrossRefPubMedPubMedCentral Bradford RD, Yoo YG, Golemac M, Pugel EP, Jonjic S, Britt WJ (2015) Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons. PLoS Pathog 11(4):e1004774CrossRefPubMedPubMedCentral
35.
go back to reference Teissier N, Delezoide AL, Mas AE, Khung-Savatovsky S, Bessières B, Nardelli J, Vauloup-Fellous C, Picone O, Houhou N, Oury JF, Van Den Abbeele T, Gressens P, Adle-Biassette H (2011) Inner ear lesions in congenital cytomegalovirus infection of human fetuses. Acta Neuropathol 122(6):763–774CrossRefPubMed Teissier N, Delezoide AL, Mas AE, Khung-Savatovsky S, Bessières B, Nardelli J, Vauloup-Fellous C, Picone O, Houhou N, Oury JF, Van Den Abbeele T, Gressens P, Adle-Biassette H (2011) Inner ear lesions in congenital cytomegalovirus infection of human fetuses. Acta Neuropathol 122(6):763–774CrossRefPubMed
Metadata
Title
Cytokine gene polymorphism associations with congenital cytomegalovirus infection and sensorineural hearing loss
Authors
B. Kasztelewicz
J. Czech-Kowalska
B. Lipka
B. Milewska-Bobula
M. K. Borszewska-Kornacka
J. Romańska
K. Dzierżanowska-Fangrat
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-2996-6

Other articles of this Issue 10/2017

European Journal of Clinical Microbiology & Infectious Diseases 10/2017 Go to the issue